Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders

NCT06432400 | Withdrawn

• 2 other identifiers: CHRD08242024-A00790-47
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 2

Brief Summary

The aim of this study is to show that early identification of PTSD and CPTSD would increase recognition of these disorders and facilitate diagnosis, referral and recovery.

Conditions

Trauma

Keywords

Post Traumatic Stress Disorder; Complex post traumatic stress disorder; Medical and Psychological Centre

Outcome Measures

Primary Outcomes (1)

• Assessment of the proportion of Post-Traumatic Stress Disorder (PTSD) in patients with substance use disorders

  Percentage of patients with PTSD among those with substance use disorders Patients with PTSD will be identified using the International Trauma Questionnaire (ITQ) : A diagnosis of PTSD requires the presence of at least one symptom in each of the following dimensions * P1 or P2 ≥ 2 * P3 or P4 ≥ 2 * 5 or P6 ≥ 2 AND * P7 or P8 or P9 ≥ 2 Score ITQ for PTSD : ≥ 8

  At the end of the study, an average of 12 month

Secondary Outcomes (4)

• Distinguishing between the prevalence of Post-Traumatic Stress Disorder (PTSD) and Complex Post-Traumatic Stress Disorder (CPTSD)

  At the end of the study, an average of 12 month

• Identification of risk factors by comparing demographic data of PTSD versus CPTSD patients

  At the end of the study, an average of 12 month

• Identification of the pathologies most associated with PTSD and CPTSD

  At the end of the study, an average of 12 month

• Comparison of the time between management and identification of patients with PTSD versus CPTSD

  At the end of the study, an average of 12 month

Study Arms (1)

Substance use disorders

OTHER

Group composed of patients suffering from disorders related to the use of alcohol, cannabis, opiates, inhalants, sedatives, hypnotics, anxiolytics, stimulants, hallucinogens (all of these disorders will have been diagnosed by a doctor before or during follow-up according to Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM 5) criteria)

Other: Patient questionnaires

Interventions

Patient questionnaires OTHER

Patients questionnaires, on paper and data collection on patients medical file

Substance use disorders

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient aged 18 or over
• Patient followed up at the adult Medical and Psychological Centre in the centres taking part in the study
• Patient suffering from disorders related to the use of alcohol, cannabis, opiates, inhalants, sedatives, hypnotics, anxiolytics, stimulants, hallucinogens (all of these disorders will have been diagnosed by a doctor before or during follow-up according to DSM 5 criteria).
• Patient aware of their substance use disorders
• Patient informed and did not object to participating in the study

You may not qualify if:

• Patient previously diagnosed with PTSD or CPTSD
• Patient agitated and/or aggressive
• Patient under guardianship/curators
• Patient who do not speak or understand French

Sponsors & Collaborators

• Hôpital NOVO: lead

Study Sites (2)

Medical and Psychological Centre - Novo Hospital - Site Beaumont-sur-Oise

Beaumont-sur-Oise, 95260, France

Location

Medical and Psychological Centre - Isarien Hospital Centre

Clermont, 60600, France

Location

MeSH Terms

Conditions

Wounds and Injuries; Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, Traumatic; Trauma and Stressor Related Disorders; Mental Disorders

Study Officials

• Déborah DELABY

  Isarien Hospital Centre

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 22, 2024
• First Posted: May 29, 2024
• Study Start: December 1, 2024
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: March 13, 2025

Record last verified: 2024-05

Locations

FR (2)